Eli Gilboa

Co-Founder at Regado Biosciences, Inc.

Eli Gilboa

Eli Gilboa

Co-Founder at Regado Biosciences, Inc.

Biography

Dr. Eli Gilboa is Co-Founder at Regado Biosciences, Inc.

Overview
Career Highlights

Regado Biosciences, Inc.

RelSci Relationships

30

Number of Boards

1

Relationships
RelSci Relationships are individuals Eli Gilboa likely has professional access to. A relationship does not necessarily indicate a personal connection.

Consultant, Biotechnology Investment Division at CLAL Industries Ltd.

Relationship likelihood: Strong

Former Head-Oncology at Les Laboratoires Servier SAS

Relationship likelihood: Strong

Former Scientific Advisor at Vaxil Bio Ltd. (Inactive)

Relationship likelihood: Strong

Former President, Chief Financial Officer & Director at Vaxil Bio Ltd. (Inactive)

Relationship likelihood: Strong

Co-Founder at Regado Biosciences, Inc.

Relationship likelihood: Average

Founder at Argos Therapeutics, Inc.

Relationship likelihood: Average

Director at Netanel Group Ltd.

Relationship likelihood: Average

Former Chairman & Chief Executive Officer at Virtual Crypto Technologies, Inc.

Relationship likelihood: Average

Visiting Scholar at New York University - Leonard N. Stern School of Business

Relationship likelihood: Average

Senior Investment Portfolio Manager at Epsilon Investment House Ltd.

Relationship likelihood: Average

Paths to Eli Gilboa
Potential Connections via
Relationship Science
You
Eli Gilboa
Co-Founder at Regado Biosciences, Inc.
Career History
Co-Founder
2001 - Prior

Regado Biosciences, Inc. is a biopharmaceutical company, which engages in the discovery and development of therapies in cardiovascular medicine using actively controlled aptamer technology. The company is focusing on new products for antithrombotic indications in the acute care and sub-acute care therapeutic setting. Its paired aptamer-active control agent technology is designed to give physicians the ability to directly control the degree of antithrombotic activity in real time on a \"per patient, per setting\" basis. The company's clinical programs are specifically concentrated on acute and sub-acute care injectable anticoagulants. Regado Biosciences was founded by Eli Gilboa, Bruce A. Sullenger and Christopher P. Rusconi on December 19, 2001 and is headquartered in Basking Ridge, NJ.

Scientific Advisor
Prior

Vaxil Bio Ltd. is a clinical stage biotechnology company which engages in the development of synthetic therapeutic and preventive vaccines. It operates through the Cancer and Tuberculosis therapeutic areas. The Cancer area comprises vaccines for metastatic breast cancer patients in combination with hormonal therapy. The Tuberculosis area involves vaccines to boost immunity in BCG immunized patients and as a theraputic vaccine in TB patients. The company was founded by Lior Carmen and Julian Levy on August 6, 2006 and is headquartered in Nes-Ziona, Israel.

Boards & Committees
Member, Scientific Advisory Board
Prior

Vaxil Bio Ltd. is a clinical stage biotechnology company which engages in the development of synthetic therapeutic and preventive vaccines. It operates through the Cancer and Tuberculosis therapeutic areas. The Cancer area comprises vaccines for metastatic breast cancer patients in combination with hormonal therapy. The Tuberculosis area involves vaccines to boost immunity in BCG immunized patients and as a theraputic vaccine in TB patients. The company was founded by Lior Carmen and Julian Levy on August 6, 2006 and is headquartered in Nes-Ziona, Israel.

Investments
Details Hidden

Regado Biosciences, Inc. is a biopharmaceutical company, which engages in the discovery and development of therapies in cardiovascular medicine using actively controlled aptamer technology. The company is focusing on new products for antithrombotic indications in the acute care and sub-acute care therapeutic setting. Its paired aptamer-active control agent technology is designed to give physicians the ability to directly control the degree of antithrombotic activity in real time on a \"per patient, per setting\" basis. The company's clinical programs are specifically concentrated on acute and sub-acute care injectable anticoagulants. Regado Biosciences was founded by Eli Gilboa, Bruce A. Sullenger and Christopher P. Rusconi on December 19, 2001 and is headquartered in Basking Ridge, NJ.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Eli Gilboa. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Eli Gilboa's profile does not indicate a business or promotional relationship of any kind between RelSci and Eli Gilboa.